Affected Systems |
|
|
|
cellular
|
√
|
√
|
abnormal endoplasmic reticulum morphology
|
|
√
|
abnormal hepatocyte mitochondrial morphology
|
|
√
|
abnormal mitochondrial chromosome morphology
|
√
|
|
abnormal mitochondrial crista morphology
|
|
√
|
abnormal mitochondrial shape
|
|
√
|
decreased mitochondrial number
|
|
√
|
dilated mitochondrion
|
|
√
|
increased hepatocyte apoptosis
|
|
√
|
increased hepatocyte proliferation
|
|
√
|
abnormal cellular respiration
|
|
√
|
oxidative stress
|
√
|
|
growth/size/body
|
|
√
|
decreased body weight
|
|
√
|
increased liver weight
|
|
√
|
homeostasis/metabolism
|
|
√
|
increased circulating alanine transaminase level
|
|
√
|
decreased liver cholesterol level
|
|
√
|
increased liver cholesterol level
|
|
√
|
increased liver triglyceride level
|
|
√
|
immune system
|
|
√
|
liver inflammation
|
|
√
|
liver/biliary system
|
√
|
√
|
abnormal liver morphology
|
|
√
|
increased liver weight
|
|
√
|
decreased liver cholesterol level
|
|
√
|
increased liver cholesterol level
|
|
√
|
increased liver triglyceride level
|
|
√
|
abnormal hepatocyte morphology
|
√
|
|
abnormal hepatocyte mitochondrial morphology
|
|
√
|
hepatic necrosis
|
|
√
|
focal hepatic necrosis
|
|
√
|
hepatic steatosis
|
|
√
|
macrovesicular hepatic steatosis
|
|
√
|
microvesicular hepatic steatosis
|
|
√
|
increased hepatocellular carcinoma incidence
|
|
√
|
liver fibrosis
|
|
√
|
pale liver
|
|
√
|
abnormal liver physiology
|
|
√
|
increased hepatocyte apoptosis
|
|
√
|
increased hepatocyte proliferation
|
|
√
|
liver inflammation
|
|
√
|
abnormal oval cell physiology
|
|
√
|
neoplasm
|
|
√
|
increased hepatocellular carcinoma incidence
|
|
√
|